(Q33942207)

English

Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots (English)

1 reference

Europe PubMed Central

30 July 2017

author name string

Joshua J Augustine

1

1 reference

Europe PubMed Central

30 July 2017

Emilio D Poggio

2

1 reference

Europe PubMed Central

30 July 2017

Peter S Heeger

3

1 reference

Europe PubMed Central

30 July 2017

Donald E Hricik

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 August 2008

1 reference

Europe PubMed Central

30 July 2017

Transplantation

1 reference

Europe PubMed Central

30 July 2017

86

1 reference

Europe PubMed Central

30 July 2017

4

1 reference

Europe PubMed Central

30 July 2017

529-534

1 reference

Europe PubMed Central

30 July 2017

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Lack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

28 July 2018

Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

29 October 2018

Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

29 October 2018

Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

29 October 2018

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108983

29 October 2018

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18724221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/TP.0B013E31818046DB

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33942207&oldid=1980022893"